- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 31, 2021 | 10.31M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $995K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $404K |
| Cash And Equivalents restated | Q3 2021 · Sep 30, 2020 | $33K |
| Cash And Equivalents restated | Q3 2021 · Dec 31, 2019 | $23K |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $6.32M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $12.91M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $6.32M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $12.91M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $995K |
| Current Assets | Q3 2021 · Dec 31, 2020 | $404K |
| Total Assets | Q3 2021 · Sep 30, 2021 | $995K |
| Total Assets | Q3 2021 · Dec 31, 2020 | $404K |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 7.23M sh |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 7.14M sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$245K |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$7.21M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$9.89M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$8.72M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$8.72M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.02 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.05 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $11.84 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $2.25 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $126K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $344K |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $11K |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $33K |
| Net Income | Q3 2021 · Sep 30, 2020 | $2.11M |
| Net Income | Q3 2021 · Sep 30, 2020 | $205K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$137K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$377K |